IMU Biosciences has formed a strategic partnership with Eurofins Transplant Genomics, with an exclusive licensing agreement to give the company access to IMU’s proprietary HD Immunology platform for transplant-related clinical development programmes.
What do the six most dangerous hospital superbugs have in common, and what makes each one distinct? MORF-Bio's live webinar compares all six genomes to find out.
Partnership provides US-based sequencing and scalable consumer genomics infrastructure, including an at-home DNA collection, to deliver PrecisionLife’s personalized wellness reports to US consumers.
